It has been nearly two months since 23andMe declared bankruptcy and the company has officially been sold. The US biotech company Regeneron has agreed to buy 23andMe and all of its assets for $256 million (even though it was valued at $50 million in March). This purchase marks the end of former 23andMe CEO Anne Wojcicki’s bid to buy the company, which included resigning in order to make an independent offer.
According to Mark Jensen, Chair and member of the Special Committee of the Board of Directors of 23andMe, Regeneron
→ Continue reading at Engadget
